Page last updated: 2024-11-03

resorcinol and Marfan Syndrome

resorcinol has been researched along with Marfan Syndrome in 1 studies

resorcinol: RN given refers to parent cpd; structure in Merck Index, 9th ed, #7951
resorcinol : A benzenediol that is benzene dihydroxylated at positions 1 and 3.

Marfan Syndrome: An autosomal dominant disorder of CONNECTIVE TISSUE with abnormal features in the heart, the eye, and the skeleton. Cardiovascular manifestations include MITRAL VALVE PROLAPSE, dilation of the AORTA, and aortic dissection. Other features include lens displacement (ectopia lentis), disproportioned long limbs and enlarged DURA MATER (dural ectasia). Marfan syndrome (type 1) is associated with mutations in the gene encoding FIBRILLIN-1 (FBN1), a major element of extracellular microfibrils of connective tissue. Mutations in the gene encoding TYPE II TGF-BETA RECEPTOR (TGFBR2) are associated with Marfan syndrome type 2.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bachet, J1
Goudot, B1
Dreyfus, G1
Brodaty, D1
Dubois, C1
Delentdecker, P1
Teimouri, F1
Guilmet, D1

Other Studies

1 other study available for resorcinol and Marfan Syndrome

ArticleYear
Surgery of acute type A dissection: what have we learned during the past 25 years?
    Zeitschrift fur Kardiologie, 2000, Volume: 89 Suppl 7

    Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Aorta; Aortic Aneurysm; Aortic Dissection

2000